21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
ANTI-CLDN6 ANTIBODY AND USE THEREOF
#5402Neutralizing Anti-SARS-CoV-2 Antibodies and Methods of Use Thereof
#5403METHODS FOR TREATING CANCER USING T CELLS WHICH EXPRESS A CHIMERIC NK RECEPTOR
#5404GLUCOCEREBROSIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
#5405ULK INHIBITORS AND METHODS OF USE THEREOF
#5406Substituted Pyrrolotriazines
#5407COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS
#5408BICYCLIC COMPOUNDS
#5409CDK Inhibitors And Their Use As Pharmaceuticals
#5410METHODS AND COMPOUNDS FOR TREATING DISORDERS
#5411METHODS OF MODULATING ANDROGEN RECEPTOR CONDENSATES
#5412ESTROGEN RECEPTOR ALPHA ANTAGONISTS AND USES THEREOF
#5413SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS
#5414Psychotropic agents and uses thereof
#5415C PRIME AGENTS FOR TREATING METABOLIC DISORDERS
#5416CONTROLLED FLOW DRUG DELIVERY IMPLANTABLE DEVICE
#5417Loading of Alginate Microspheres
#5418LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE,PREPARATION METHOD THEREFOR, AND USES THEREOF
#5419HYDROGEL PRODRUG FOR TREATMENT
#5420TARGETED BIFUNCTIONAL DEGRADERS
#5421DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY
#5422CANCER VACCINE AND METHOD OF USE THEREOF
#5423TREATMENT OF LOWER URINARY TRACT EPITHELIUM WITH GLUCAGON LIKE PEPTIDE 2
#5424COMBINATION TREATMENTS FOR CHOLESTASIS
#5425Methods and Compositions for Treatment of Disease
#5426METHODS AND COMPOSITIONS FOR TREATMENT OF AUTOIMMUNE CONDITIONS
#5427Treatment of rhinosinusitis with P-glycoprotein inhibitors
#5428HERBAL COMPOSITION COMPRISING SOLANUM NIGRUM FOR THE TREATMENT OF CANCER
#5429TREATMENT METHOD FOR CARDIAC HYPERTROPHY
#5430CANNABIS PREVENTS NK INACTIVATION IN CANCER AND INCREASES NK FUNCTION
#5431USE OF IMMUNOTHERAPY AND MICROBIOME MODULATION TO TREAT CANCER
#5432Purified anthelmintic compositions and related methods
#5433COMPOSITIONS AND METHODS FOR REDUCING CYTOKINE EXPRESSION
#5434Mesenchymal Stem Cell Derived Exosomes And Methods
#5435EXPEDITED ADMINISTRATION OF ENGINEERED LYMPHOCYTES
#5436TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE (AD)
#5437Treatment Of Inflammation With Glucocorticoids And Angiopoietin-Like 7 (ANGPTL7) Inhibitors
#5438Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
#5439CHROMIUM CONTAINING COMPOSITIONS FOR IMPROVING HEALTH AND FITNESS
#5440COMBINATION DRUG FOR TREATING RENAL CANCER AND POTENTIATOR FOR THERAPEUTIC EFFECTS OF TYROSINE KINASE INHIBITOR
#5441METHODS OF TREATING HEART FAILURE WITH VIBEGRON
#5442TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISORDERS
#5443Optically active azabicyclo ring derivative
#5444INHIBITORS OF CYTOCHROME P450 FAMILY 7 SUBFAMILY B MEMBER 1 (CYP7B1) FOR USE IN MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS
#5445METHODS OF TREATING EYE PAIN AND EYE DISORDERS
#5446MODULATION OF DRUG-DRUG INTERACTIONS OF VADADUSTAT
#5447METHODS AND COMPOSITIONS UTILIZING RRx-001 COMBINATION THERAPY FOR RADIOPROTECTION
#5448Treatment of Hypertension-Related and Vascular Diseases
#5449STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME
#5450TOPICAL COMPOSITIONS AND METHODS FOR TREATMENT
#5451PHARMACEUTICALLY ACCEPTABLE SALTS OF MESDOPETAM AND USES THEREOF
#5452COMPOSITIONS FOR PREVENTING AND TREATING VIRAL INFECTIONS
#5453PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
#5454ABSORBENT STRUCTURE FOR ABSORBENT ARTICLES
#5455METHODS AND COMPOSITIONS FOR NEOADJUVANT AND ADJUVANT UROTHELIAL CARCINOMA THERAPY
#5456Methods for detecting and predicting cancer
#5457Driving Axon Regeneration by Activating STAT1 Signaling and cGAS-STING Pathway
#5458MODULATION OF GYS1 EXPRESSION
#5459CHAPERONIN-CONTAINING TCP-1 INHIBITORS FOR THE TREATMENT OF CANCER
#5460METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#5461ANTI-KIT ANTIBODIES AND USES THEREOF
#5462METHODS AND COMPOSITIONS FOR ACTIVATION OF T CELLS USING NANOPARTICLES CONJUGATED WITH MULTIPLE LIGANDS FOR BINDING RECEPTORS ON T CELLS
#5463ANTIBODY AGAINST NKP46 AND APPLICATION THEREOF
#5464ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF
#5465Antibodies to PfGARP kill malaria parasites and protect against infection and severe disease
#5466ANTIBODY-CYTOKINS ENGRAFTED PROTEINS AND METHODS OF US IN THE TREATMENT OF CANCER
#5467ACYLATED GLUCAGON ANALOGUES
#5468HETEROCYCLIC INHIBITORS OF CD73 FOR TREATMENT OF DISEASE
#54692-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
#5470TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF
#5471COMPOUND FOR THE TREATMENT OF CANCER
#5472FLUORINATED INTEGRIN ANTAGONISTS
#5473Diacylglycerol Acyl Transferase 2 Inhibitors
#5474DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY
#5475USE OF OREGOVOMAB AND BEVACIZUMAB, PACLITAXEL, CARBOPLATIN FOR TREATMENT OF BRCA-WILD TYPE PLATINUM SENSITIVE RECURRENT
#5476COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF HEARING LOSS
#5477P AERUGINOSA PCRV-LINKED ANTIGEN VACCINES
#5478ACTIVE CANCER IMMUNOTHERAPY BY IMMUNE MODULATION VIA GLOBO SERIES ANTIGENS
#5479METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#5480Compositions and Methods for Enhancing Anti-Viral Therapies
#5481COMPOSITIONS AND METHODS FOR TREATMENT OF SENSITIVE SKIN
#5482THERAPEUTIC USES OF DULAGLUTIDE
#5483CHINESE HERBAL MEDICINE ANTI-VIRUS ARECA NUT PRODUCT AND PREPARATION METHOD THEREOF, AND ARECA NUT ADDITIVE AGENT
#5484SENECA VALLEY VIRUS (SVV) CELLULAR RECEPTOR TARGETED ONCOTHERAPY
#5485PROSTATE NEOANTIGENS AND THEIR USES
#5486SMALL EXTRACELLULAR VESICLES FOR ATTENUATING POST-OPERATIVE PAIN
#5487Nucleoside phosphoramidate prodrugs
#5488ABIRATERONE PRODRUGS
#5489METHODS FOR TREATING PULMONARY HYPERTENSION
#5490MODULATORS OF ARALAR FOR TREATING NEUROLOGICAL DISORDERS
#5491METHOD AND COMBINATION FOR TREATING TUMORS
#5492METHODS OF TREATING CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION USING BTK INHIBITORS
#5493METHODS AND COMPOSITIONS COMPRISING A BRAF INHIBITOR AND A MEK INHIBITOR
#5494METHODS OF TREATING HIV
#5495COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF
#5496Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor
#5497TOPICAL FORMULATIONS OF A JAK 1/3 INHIBITOR AND METHODS OF USE THEREOF FOR TREATMENT OF ATOPIC DERMATITIS AND OTHER SKIN CONDITIONS
#5498OPHTHALMIC COMPOSITIONS FOR PRESBYOPIA
#5499METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE
#5500Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
#5501METHODS OF TREATING PULMONARY DISEASES AND DISORDERS
#5502Compounds for treating TNBC
#5503Methods of Reducing Risk of Prostate Cancer Progression
#5504NOVEL ANTITUMORAL USE OF CABAZITAXEL
#5505METHOD FOR PREVENTING OR TREATING LIVER DISEASE
#5506NANOSUSPENSIONS OF SALSALATE AND METHODS OF USING THE SAME
#5507Compositions and methods for stimulating ventilatory and/or respiratory drive
#5508PHARMACEUTICAL FORMULATIONS OF NAPROXEN FOR SOFT GEL ENCAPSULATION AND COMBINATIONS THEREOF
#5509TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FMO3/TMAO PATHWAY
#5510Novel Method for Preparation of Nanoparticles Comprising Cell Penetrating Peptides
#5511METHODS FOR THE EXTRACTION OF DISPERSIBLE MICROCAPSULES
#5512MICELLE RELEASING THERMOSENSITIVE HYDROGELS AS A THERAPEUTIC DELIVERY SYSTEM
#5513RADIATION SENSITIZER OF ANTI-CANCER CHEMOTHERAPY SENSITIZER
#5514NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
#5515ORAL FELINE FEED AND METHODS FOR CONTROLLING FLEA INFESTATIONS IN A FELINE
#5516Food-allergen specific antibody compositions
#5517COMPOSITIONS AND METHODS FOR DETECTING TRYPANOSOMA CRUZI INFECTION
#5518MICRORNA COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF NERVOUS SYSTEM DYSFUNCTION
#5519COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA
#5520COMPLEMENT COMPONENT 9 (C9) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#5521DELIVERY OF BIOMOLECULES TO PBMCs TO MODIFY AN IMMUNE RESPONSE
#5522Methods for Treating Multiple Myeloma
#5523Antibodies Binding to Human PAD4 and Uses Thereof
#5524COMBINATION THERAPIES WITH ANTI CD40 ANTIBODIES
#5525ANTIBODIES, USES & METHODS
#5526FOLATE RECEPTOR 1 ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREOF
#5527PLATFORM TECHNOLOGY FOR TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND/OR AUTOIMMUNOLOGICAL DISEASES
#5528HETERODIMERIC FC CYTOKINES AND USES THEREOF
#5529COMPOSITIONS AND METHODS FOR MODULATING MYC EXPRESSION
#5530COMPOUNDS AND METHODS FOR MODULATING HER2
#5531NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS
#5532MACROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF
#5533BENZAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT
#5534TREATMENTS OF PRADER-WILLI SYNDROME
#5535Pyrrolopyrimidine ITK inhibitors
#5536METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS
#5537HETEROARYL-BIPHENYL AMINES FOR THE TREATMENT OF PD-L1 DISEASES
#5538KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE
#5539Antibacterial Compounds
#5540SUBSTITUTED N-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-5-YL)ARYLSULFONAMIDE ANALOGS AS MODULATORS OF CEREBLON PROTEIN
#5541Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
#5542Deuterated compounds and uses thereof
#5543SYNERGISTIC EFFECTS BETWEEN AURISTATIN-BASED ANTIBODY DRUG CONJUGATES AND INHIBITORS OF THE PI3K-AKT MTOR PATHWAY
#5544ANHYDROUS ORAL PHARMACEUTICAL SUSPENSIONS
#5545HER2/neu-Specific Antibodies and Methods of Using Same
#5546COMPOSITIONS AND METHODS FOR TREATMENT OF RHEUMATOID ARTHRITIS AND ACCELERATED ATHEROSCLEROSIS
#5547ANTIBODIES THAT BIND THE TUMOR (T) ANTIGEN OF MERKEL CELL POLYOMAVIRUS AND RELATED DIAGNOSTICS
#5548Use of pertussis toxin as a therapeutic agent
#5549COLLAGENOUS EXTRACTS FOR USE AS A MEDICAMENT
#5550STABLE ASCORBIC ACID COMPOSITIONS AND METHODS OF USING SAME
#5551ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY
#5552IMMUNOMODULATORY COMPOSITIONS COMPRISING MICROBIAL ENTITIES
#5553OBLIGATE ANAEROBIC HUMAN INTESTINAL MICROBE FOR CANCER TREATMENT, AND USE THEREOF
#5554Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
#5555ANTI-PSMA ANTIBODIES AND CAR-T STRUCTURES
#5556MIR200C-EPCAM AXIS REPROGRAMED IMMUNE CELLS FOR ENHANCED ANTI-TUMOR FUNCTION
#5557COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS
#5558TREATMENT OF CANCER PATIENTS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH BRAF INHIBITORS AND/OR MEK INHIBITORS
#5559PATIENT SELECTION FOR TREATMENT WITH DENDRITIC CELL VACCINATION
#5560METHODS OF TREATING B-CELL PROLIFERATIVE DISORDER
#5561CHEMOVACCINATION AGAINST PLASMODIUM INFECTION WITH SELECTIVE PLASMEPSIN X INHIBITORS
#5562HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS
#5563MEDICAMENT FOR TREATMENT AND/OR PROPHYLACTIC TREATMENT OF CANCERS
#5564TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS
#5565Compositions and methods for treating non-hemorrhagic closed head injury
#5566AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES
#5567METHODS AND COMPOSITIONS FOR TREATING 4- HYDROXYPHENYLPYRUVATE DIOXYGENASE-LIKE (HPDL)-RELATED DISEASES OR DISORDERS
#5568AMINONAPHTHOQUINONE COMPOUNDS FOR TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES
#5569Compositions, methods and uses for thermally stable multi-targeted antigens
#5570METHOD FOR THE PRODUCTION OF PRECISELY SIZED MACRO- AND MICRO-ELP CONTAINING PARTICLES FOR THE DELIVERY OF THERAPEUTIC AGENTS
#5571METHODS AND PRODUCTS FOR TREATING SUBJECTS WITH AUTISM SPECTRUM DISORDERS
#5572MEDICAL IMPLANT
#5573NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
#5574NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
#5575NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
#5576METHODS OF MODELING IN VIVO EFFICACY OF DRUG COMBINATIONS FOR TREATMENT OF VIRAL INFECTIONS
#5577COVID MULTI-BIOME
#5578Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
#5579C/EBP Alpha Short Activating RNA Compositions and Methods of Use
#5580HUMAN MONOCLONAL ANTIBODIES TO GANGLIOSIDE GD2
#5581METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS
#5582Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
#5583ANTIBODY MOLECULES FOR CANCER TREATMENT
#5584Anti-Human MSLN Antibody And Application Thereof
#5585OPTIMIZED PEPTIDES FOR TARGETING HUMAN NERVES AND THEIR USE IN IMAGE GUIDED SURGERY, DIAGNOSTICS AND THERAPEUTIC DELIVERY
#5586MASP INHIBITORY COMPOUNDS AND USES THEREOF
#5587CD73 INHIBITORS
#5588Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As PRMT5 Inhibitors
#5589Amino-triazolopyridine Compounds and Their Use in Treating Cancer
#5590METHODS AND COMPOUNDS FOR TREATING FRIEDREICH'S ATAXIA
#5591SPIROCYCLIC-SUBSTITUTED 6,7-DIHYDRO-PYRANO[2,3-d]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT
#5592HER2 MUTATION INHIBITORS
#5593SUBSTITUTED FUSED BICYCLIC COMPOUND AS KINASE INHIBITOR AND USE THEREOF
#5594PROTEIN TYROSINE PHOSPHATASE INHIBITORS
#5595Fused bicyclic RAF inhibitors and methods for use thereof
#55962,3-DIHYDRO-4H-BENZO[B][1,4]OXAZIN-4-YL)(5-(PHENYL)-PYRIDIN-3-YL)METHANONE DERIVATIVES AND SIMILAR COMPOUNDS AS CYP11A1 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER
#5597HETEROCYCLIC INHIBITORS OF PCSK9
#5598SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF
#5599ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS
#5600SOLABEGRON ZWITTERION AND USES THEREOF
#5601CARDIOVASCULAR DISEASE MEDICATION ADMINISTRATION METHODS
#5602AAV VECTORS TARGETING T-CELLS
#5603Hydrogel prodrug for treatment
#5604MINIMALLY TOXIC PRODRUGS
#5605EPITOPE PEPTIDE OF RAS G13D MUTANT AND T CELL RECEPTOR RECOGNIZING RAS G13D MUTANT
#5606THERAPEUTIC COMBINATIONS OF TDFRPs AND ADDITIONAL AGENTS AND METHODS OF USE FOR THE REVERSAL OF FIBROSIS
#5607COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CORONAVIRUS INFECTIONS
#5608Formulated and/or Co-Formulated Liposome Compositions Containing Toll-Like Receptor ("TLR") Agonist Prodrugs Useful In The Treatment of Cancer and Methods Thereof C
#5609APOMERS
#5610HLA-RESTRICTED VCX/Y PEPTIDES AND T CELL RECEPTORS AND USE THEREOF
#5611AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE GASTROINTESTINAL SYSTEM
#5612IMMUNOSTIMULATORY BACTERIA FOR THE TREATMENT OF CANCER
#5613CD38-NAD+ REGULATED METABOLIC AXIS IN ANTI-TUMOR IMMUNOTHERAPY
#5614ANTIBODIES, COMBINATIONS COMPRISING ANTIBODIES, BIOMARKERS, USES & METHODS
#5615COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE
#5616Chimeric Cytokine Receptors
#5617IN VITRO METHODS AND COMPOSITIONS FOR ENHANCING THE ACTIVATION OF DENDRITIC CELLS AND T CELLS, AND FOR INDUCING A TH-1 IMMUNE RESPONSE
#5618PHARMACEUTICAL COMPOSITION FOR USE IN THE PREVENTION OR TREATMENT OF A CONDITION ASSOCIATED WITH A REDUCTION IN THE NUMBER OF LACTOBACILLI IN THE VAGINA
#5619USE OF NICOTINAMIDE MONONUCLEOTIDE (NMN) FOR THE PREVENTION AND/OR TREATMENT OF RHEUMATOID ARTHRITIS, AND CORRESPONDING COMPOSITIONS
#5620METHOD TO TREAT LIPID DYSREGULATION BY MODULATING ACTIVITY OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) PROTEIN WITH SMALL MOLECULE LIGANDS
#5621METHOD OF TREATING VARIOUS DISORDERS AND CONDITIONS USING CITICOLINE
#5622SHP2 PHOSPHATASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME
#5623Methods Of Treating Cancer With Transmembrane Protein 16F (TMEM16F) Inhibitors
#5624COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT
#5625ENTACTOGEN-ASSISTED THERAPY FOR ALCOHOL USE DISORDER AND ADDICTION-RELATED CONDITIONS AND COMORBIDITIES
#5626METHODS FOR INHIBITING CORONAVIRUSES USING SULFORAPHANE
#5627THERAPEUTIC USES OF L-4-CHLOROKYNURENINE
#5628AN ARTIFICIAL TRAP-CAGE, ITS USE AND METHOD OF PREPARING THEREOF
#5629CATIONIC POLYMER-FORMULATED NANOPARTICLES AND METHODS OF USE
#5630COMPOSITION FOR PENETRATING BLOOD-BRAIN BARRIER, CONTAINING SONOSENSITIVE LIPOSOMES AS ACTIVE INGREDIENTS
#5631TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE (IDS)
#5632BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP
#5633ANTI-TIGIT ANTIBODIES AND METHODS OF USE
#5634MULTISPECIFIC ANTIBODIES AND USES THEREOF
#5635MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER
#5636BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV
#5637HIV VACCINES AND METHODS OF MAKING AND USING
#5638Methods and composition for neutralization of influenza
#5639Methods and composition for neutralization of influenza
#5640Methods and composition for neutralization of influenza
#5641Methods and composition for neutralization of influenza
#5642NOVEL BICYCLIC PEPTIDES
#5643Compositions and Methods of Treatment Using CRRL 191
#5644STAPLED PEPTIDES AND METHODS THEREOF
#5645TLR7 agonists
#5646NMN AND DERIVATIVES FOR ITS USE IN THE TREATMENT OF DEPRESSION AND/OR ANXIETY IN PATIENTS HAVING A FORM OF PARKINSONISM
#5647PYRIDINE-2-AMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#5648KRAS INHIBITOR AND PHARMACEUTICAL USES THEREOF
#5649Inhibitors of (α-v)(β-6) integrin
#5650IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS IRAK4 INHIBITORS AND THEIR USE IN THE TREATMENT OF DISEASE
#5651Polymorphisms of HM30181 mesylate
#5652ESTER SUBSTITUTED ION CHANNEL BLOCKERS AND METHODS FOR USE
#5653ANTIVIRAL COMPOUNDS AND METHODS
#5654COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTOM ASSOCIATED WITH GOUT OR HYPERURICEMIA
#5655ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES
#5656QUATERNARY AMMONIUM COMPOUNDS AS ANTIMICROBIALS
#5657Lipid nanoparticle compositions for delivering circular polynucleotides
#5658USE OF D9-METHADONE FOR POSTOPERATIVE PAIN RELIEF
#5659COLLAGEN COMPOSITIONS AND USES FOR BIOMATERIAL IMPLANTS
#5660COLLAGEN COMPOSITIONS AND USES FOR BIOMATERIAL IMPLANTS
#5661Biosurfactant Formulations for Use in Skincare and Wound Treatment
#5662FIBRIN-BINDING COMPOUNDS FOR IMAGING AND TREATMENT
#5663METHODS AND COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS
#5664MATERIALS AND METHODS FOR THE TREATMENT OF LYSOSOMAL ACID LIPASE DEFICIENCY (LAL-D)
#5665COMPOSITIONS AND METHODS FOR TARGETED ANTIFIBROTIC THERAPY IN CHRONIC PANCREATITIS
#5666STEROID ACID-PEPTIDE BASED CYTOTOXIC COMPOUNDS
#5667CHLOROTOXIN DERIVATIVES AND USE THEREOF
#5668Regulation of Butyrophilin subfamily 3 member A1 (BTN3A1, CD277)
#5669CANCER TREATMENT COMBINATIONS
#5670COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS
#5671METHODS OF TREATING METABOLIC DISORDERS WITH FGF21 VARIANTS
#5672PEPTIDES FOR TREATING DISEASE AND REDUCING SYMPTOMS RELATED TO MULTIPLE SCLEROSIS
#5673Modified Extracellular Domain of Granulocyte Colony-Stimulating Factor Receptor (G-CSFG) and Cytokines Binding Same
#5674ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF
#5675COMBINATION THERAPIES
#5676COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS
#5677USE OF SODIUM TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] FOR TREATING CANCERS
#5678Managing the Acute and Long-Term Effects of Coronaviral Infections and Compositions Related Thereto
#5679COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH
#5680SMALL THERAPEUTIC MOLECULES CAPABLE OF INHIBITING THE CATALYTIC ACTIVITY OF THE MAIN PROTEASE ENZYME OF SARS-COV-2
#5681Treatment of a senescence-associated ocular disease or disorder using a Bcl-xL selective inhibitor
#5682HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS
#5683METHODS OF TREATING CANCER USING B-RAF INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS
#5684METHODS FOR TREATING OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
#5685MEBENDAZOLE POLYMORPH FOR TREATMENT AND PREVENTION OF TUMORS
#5686Apparatus for treating Benign Prostatic Hyperplasia
#5687METHODS OF TREATING AND PREVENTING ENDOTHELIAL DYSFUNCTION USING BARDOXOLONE METHYL OR ANALOGS THEREOF
#5688COMPOSITION FOR PREVENTING OR TREATING BREAST CANCER COMPRISING COMPOUND DERIVED FROM DENDROPANAX MORBIFERUS
#5689Composition for Treating Hair and Scalp
#5690COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL DISEASES
#5691Macrophage Targeted Immunotherapeutics
#5692Tamper resistant dosage forms
#5693FORMULATIONS AND METHODS FOR PULMONARY DELIVERY OF ACTIVE PHARMACEUTICAL INGREDIENTS
#5694SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NEUROTROPHIC AND NEUROPROTECTIVE COMPOSITIONS
#5695DELTA-2-TUBULIN AS A BIOMARKER AND THERAPEUTIC TARGET FOR PERIPHERAL NEUROPATHY
#5696METHODS, ASSAYS AND COMPOSITIONS FOR MEASURING BRAIN DAMAGE OR HARM DURING SURGERY
#5697METHOD FOR TREATING HEPATOCELLULAR CARCINOMA
#5698BIOMARKERS FOR CANCER TREATMENT
#5699ANTIBODY AND TAXANE COMBINATION THERAPY
#5700USE OF ESCULENTIN AND ITS DERIVATIVES FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS